๐ฐ Chris Ehrlich News
Chris Ehrlich News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chris Ehrlich. Real-time updates on events, politics, business and more.
February 2, 2024
The system was installed around March, but by September it still wasn't working
June 5, 2023
CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to... | June 5, 2023
April 23, 2023
Former Ohioan Chris Ehrlich, who has written for the Newark Advocate, shares poem-style tales in โParts of a Life: 40 Stories on Youth to Adulthood.โ
April 6, 2023
"Parts of a Life: 40 Stories on Youth to Adulthood" by Chris Ehrlich tells a story about each of the common experiences in life.
October 31, 2022
The resources of the combined company look to provide Intrinsic with the capital to advance OM002, a synthetic biology-produced HMO drug candidate.
September 20, 2022
SAN FRANCISCO, Sept. 20, 2022 (GLOBE NEWSWIRE) -- ProLynx, Inc., a biotechnology company with a novel platform technology for half-life extension of therapeutics, enabling novel and potentially best-in-class
September 20, 2022
ProLynx appoints Richard King as Chief Executive Officer and Chris Ehrlich as Board Director
June 6, 2022
Join us as a panel of AI industry experts discuss โย over Twitter โย key strategies for expanding your company's AI usage.
January 10, 2022
Join us on January 18 at 11 AM PT, when @eWEEKNews hosts its monthly #eWEEKChat. The topic will be โDigital Transformation Trends."
August 26, 2021
26.08.2021 - Common stock and warrants expected to commence trading on Nasdaq on August 26, 2021 under the ticker symbols EFTR and EFTRWSAN DIEGO, Aug. 25, 2021 (GLOBE NEWSWIRE) - eFFECTOR Therapeutics, Inc. (eFFECTOR), a leader in the development of selective ... Seite 1